Adherence and protease inhibitor

NEW YORK, July 18 (Praxis Press) The complexity of antiretroviral regimens may be an obstacle to adherence among patients infected with the human immunodeficiency virus (HIV). Paterson and colleagues evaluated the importance of adherence to protease inhibitor therapy among HIV-infected patients (see paper). Good adherence was associated with decreased virologic failure, fewer days of hospitalization, and fewer opportunistic infections. An adherence level of 95% was identified as a critical level

July 21, 2000

NEW YORK, July 18 (Praxis Press) The complexity of antiretroviral regimens may be an obstacle to adherence among patients infected with the human immunodeficiency virus (HIV). Paterson and colleagues evaluated the importance of adherence to protease inhibitor therapy among HIV-infected patients (see paper). Good adherence was associated with decreased virologic failure, fewer days of hospitalization, and fewer opportunistic infections. An adherence level of 95% was identified as a critical level for optimal outcomes. Adherence is essential to successful protease inhibitor therapy, and underlying causes of poor adherence should be identified and addressed.

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham